|
Vaccine Detail
Measles Virus Vaccine VVM |
Vaccine Information |
- Vaccine Name: Measles Virus Vaccine VVM
- Target Pathogen: Measles virus
- Target Disease: Measles
- Vaccine Ontology ID: VO_0011537
- Type: Recombinant vector vaccine
- Status: Research
- M matrix protein
gene engineering:
- Type: Recombinant vector construction
- Description:
- Detailed Gene Information: Click Here.
- Immunization Route: Intraperitoneal injection (i.p.)
|
Host Response |
Rat Response
- Host Strain: Lewis
- Vaccination Protocol: To determine the protective effect of individual measles virus (MV) proteins, 2- to 3-week-old suckling rats were immunized either once, twice or three times at 5 to 7 day intervals by i.p. injections of 10^7 p.f.u, of recombinant vaccinia virus (VV) expressing individual structural proteins or VV-wt (Brinckmann et al., 1991).
- Challenge Protocol: Three to 5 days after the last recombinant VV injection, the animals were challenged by intracerebral (i.c.) infection with the neurotropic rat brain-adapted MV strain CAM/RBH (0.5 × 10^4 to 8 x 10 ~ TCID50) (Brinckmann et al., 1991).
- Efficacy: Lewis rats were immunized with recombinant vaccinia virus (VV) expressing various proteins of measles virus (MV). VVM (Matrix Protein) -immunized rats were partially protected from MV challenge (Brinckmann et al., 1991).
|
References |
Brinckmann et al., 1991: Brinckmann UG, Bankamp B, Reich A, ter Meulen V, Liebert UG. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. The Journal of general virology. 1991; 72 ( Pt 10); 2491-2500. [PubMed: 1833505].
|
|